HIV-1 infection, as documented by any federally approved, licensed HIV rapid test performed in conjunction with screening (or enzyme linked immunosorbent assay [ELISA], test kit, and confirmed by Western blot or other approved test); alternatively, this documentation may include a record demonstrating that another physician has documented the participant's HIV status based on either: 1) approved diagnostic tests, or 2) the referring physician's written record that HIV infection was documented, with supporting information on the participant’s relevant medical history and/or current management of HIV infection
Known history of HIV infection
HIV infection.
HIV-1 infection, as documented by any federally approved, licensed HIV rapid test performed in conjunction with screening (or enzyme linked immunosorbent assay [ELISA], test kit, and confirmed by western blot or other approved test); alternatively, this documentation may include a record demonstrating that another physician has documented the participant's HIV status based on either: 1) approved diagnostic tests, or 2) the referring physician's written record that HIV infection was documented, with supporting information on the participant's relevant medical history and/or current management of HIV infection
HIV infection
Known history of HIV.
A known history of HIV
EXCLUSION - TREATMENT: Active infection with HIV or HTLV
Has known HIV
Known positiv test for HIV
DONOR: Infection with HIV
Known HIV infection.
Known HIV infection.
Patients with documented immunodeficiency such as HIV infection.
TREATMENT WITH SJCAR19: History of HIV infection
Known history of HIV
Subjects with significant history of systemic immunosuppression due to drugs or infection with HIV or HTLV 1.
HIV infection
Known history of HIV infection (testing not mandatory).
Any HIV status
Known HIV-infected patients
PART 2: History of HIV infection
Patients with known HIV disease
Known history of HIV infection.
Any HIV status
HIV infection
Patients with a known history of HIV.
HIV infection or a known HIV-related malignancy.
Subject has known HIV infection
Known to be HIV+
History of HIV infection.
Known HIV infection.
Known infection with HIV (testing of patients not known to be infected with HIV is not required prior to study entry)
ARM B: Known HIV infection
HIV infection
Known history of infection with HIV.
Known history of infection with HIV.
HIV negative
Subjects with known HIV infection
HIV infection
HIV related disease or known or suspected HIV+
Subjects with HIV infection.
HIV.
Subjects with documentation of confirmed HIV-1 infection (i.e. HIV-positive), and a hematologic malignancy who meets all other eligibility requirements must:
Known HIV infection.
Known history of HIV infection. Testing for HIV status is not necessary unless clinically indicated
HIV or HTLV infection
Subjects with uncontrolled human immunodeficiency virus (HIV) are not eligible; controlled HIV is defined as a CD4 count > institutional lower limit of normal and no current co-infection; uncontrolled HIV is all other HIV infection; note that patients with controlled infection should be allowed to participate only if they are not receiving prohibited cytochrome P450 (CYP) interactive medications
Known carrier of HIV.
Known HIV carrier
Known infection with HIV
HIV infection.
Known HIV infection;
Patients with treated HLTV or HIV
History of HIV infection.
Prior history of HIV-positivity (routine HIV testing is not required pre-treatment)
HIV-1 infection, as documented by a rapid HIV test or any FDA-Approved HIV-1 Enzyme or Chemiluminescence Immunoassay (E/CIA) test kit and confirmed by Western Blot at any time prior to study entry. HIV antigen, plasma HIV-1 RNA, or a secondary antibody test by a method other than rapid HIV and E/CIA is acceptable as an alternative test. Alternatively, if a rapid HIV test or any FDA-Approved HIV-1 Enzyme or Chemiluminescence Immunoassay (E/CIA) test is not available, two HIV-1 RNA values ? 2000 copies/mL at least 24 hours apart performed by any laboratory that has CLIA certification, or its equivalent, may be used to document infection.
HIV infection
Known human immunodeficiency virus (HIV) infection or a known HIV-related malignancy. Note: HIV testing is not required unless there is any clinical suspicion that the patient might be HIV positive.
Patients who are HIV+ will be excluded
Patients with known HIV.
HIV infection
HIV infection; there is theoretical concern that the degree of immune suppression associated with the treatment may result in progression of HIV infection
DONOR: Infection with HIV
Known HIV infection
HIV infection (due to increased risk of severe infection and unknown interaction of moxetumomab pasudotox with antiretroviral drugs)
Evidence of HIV infection
HIV negative.
Documentation of HIV status; if participant is HIV positive, HIV-1 infection, as documented by any federally approved, licensed HIV rapid test performed in conjunction with screening (or enzyme-linked immunosorbent assay [ELISA] test kit, and confirmed by Western blot or other approved test, or HIV rapid multispot antibody differentiation assay); alternatively, this documentation may include a record demonstrating that another physician has documented the participant's HIV status based on either: 1) approved diagnostic tests, or 2) the referring physician's written record that HIV infection was documented, with supporting information on the participant's relevant medical history and/or current management of HIV infection\r\n* If the participant is HIV negative, documentation of a negative result for any federally approved, licensed HIV rapid test within 4 weeks prior to study enrollment will suffice; if the initial rapid test is positive, further approved confirmatory test results must be present to document the subject’s HIV status
Has a known history of HIV.
Patients with HIV
Known HIV infection
Known HIV infection.
Patient has a known history of HIV infection (testing not mandatory).
Known HIV infection
Patients with the presence of an infection including abscess or fistulae, or known infection with hepatitis B or C or HIV
Known HIV infection.
Subjects with known HIV infection
HIV infection; patients should provide consent for HIV testing according to the institution’s standard practice
Known HIV infection
Known history of HIV infection.
Known HIV infection.
History of HIV infection.
Known HIV infection
Kown history of HIV.
HIV infection
HIV infection with a last known or suspected CD4 count of <50/mm3
History of HIV disease and/or treatment with anti-HIV agents.
Known HIV infection
Known HIV+ patients.
A positive HIV test result (enzyme-linked immunosorbent assay [ELISA] and Western blot) or history of known HIV; an HIV test will not be required; however, previous medical history will be reviewed
Known active infection with HIV
Known HIV infection.
Known active infection with HIV
Any HIV status